<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK84550" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK84550/" /><meta name="ncbi_pagename" content="Cartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Cartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Cartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/05/24" /><meta name="citation_author" content="Outi Mäkitie" /><meta name="citation_author" content="Svetlana Vakkilainen" /><meta name="citation_pmid" content="22420014" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK84550/" /><meta name="citation_keywords" content="Metaphyseal Dysplasia without Hypotrichosis (MDWH)" /><meta name="citation_keywords" content="Anauxetic Dysplasia (AD)" /><meta name="citation_keywords" content="Cartilage-Hair Hypoplasia (CHH)" /><meta name="citation_keywords" content="RMRP" /><meta name="citation_keywords" content="Cartilage-Hair Hypoplasia-Anauxetic Dysplasia Spectrum Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Cartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Outi Mäkitie" /><meta name="DC.Contributor" content="Svetlana Vakkilainen" /><meta name="DC.Date" content="2018/05/24" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK84550/" /><meta name="description" content="The cartilage-hair hypoplasia – anauxetic dysplasia (CHH-AD) spectrum disorders are a continuum that includes the following phenotypes:" /><meta name="og:title" content="Cartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="The cartilage-hair hypoplasia – anauxetic dysplasia (CHH-AD) spectrum disorders are a continuum that includes the following phenotypes:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK84550/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/chh/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK84550/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AB367DFC84BA10000000007DC03E8.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK84550_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK84550_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cpt2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cvt/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK84550_"><span class="title" itemprop="name">Cartilage-Hair Hypoplasia &#x02013; Anauxetic Dysplasia Spectrum Disorders</span></h1><p class="contrib-group"><span itemprop="author">Outi M&#x000e4;kitie</span>, MD, PhD and <span itemprop="author">Svetlana Vakkilainen</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK84550_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK84550_ai__"><div class="contrib half_rhythm"><span itemprop="author">Outi M&#x000e4;kitie</span>, MD, PhD<div class="affiliation small">Children's Hospital<br />University of Helsinki and Helsinki University Hospital<br />Folkh&#x000e4;lsan Research Center<br />Helsinki, Finland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="if.iknisleh@eitikam.ituo" class="oemail">if.iknisleh@eitikam.ituo</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Svetlana Vakkilainen</span>, MD<div class="affiliation small">Children's Hospital<br />University of Helsinki and Helsinki University Hospital<br />Folkh&#x000e4;lsan Research Center<br />Helsinki, Finland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@hctivokujtsokanaltevs" class="oemail">moc.liamg@hctivokujtsokanaltevs</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">March 15, 2012</span>; Last Update: <span itemprop="dateModified">May 24, 2018</span>.</p><p><em>Estimated reading time: 25 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="chh.Summary" itemprop="description"><h2 id="_chh_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The cartilage-hair hypoplasia &#x02013; anauxetic dysplasia (CHH-AD) spectrum disorders are a continuum that includes the following phenotypes:</p><ul><li class="half_rhythm"><div>Metaphyseal dysplasia without hypotrichosis (MDWH)</div></li></ul><ul><li class="half_rhythm"><div>Cartilage-hair hypoplasia (CHH)</div></li><li class="half_rhythm"><div>Anauxetic dysplasia (AD)</div></li></ul><p>CHH-AD spectrum disorders are characterized by severe disproportionate (short-limb) short stature that is usually recognized in the newborn, and occasionally prenatally because of the short extremities. Other findings include joint hypermobility, fine silky hair, immunodeficiency, anemia, increased risk for malignancy, gastrointestinal dysfunction, and impaired spermatogenesis. The most severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, AD, has the most pronounced skeletal phenotype, may be associated with atlantoaxial subluxation in the newborn, and may include cognitive deficiency. The clinical manifestations of the CHH-AD spectrum disorders are variable, even within the same family.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis of the CHH-AD spectrum disorders is based on clinical findings, characteristic radiographic findings, and in some cases, evidence of immune dysfunction, macrocytic anemia, and/or gastrointestinal problems. If clinical and radiographic findings are inconclusive, identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>RMRP</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can confirm the diagnosis and allow for family studies.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i></p><ul><li class="half_rhythm"><div>In the newborn. Hypoplastic anemia may require repeated blood transfusions; <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> megacolon or Hirschsprung disease may require surgical resection.</div></li><li class="half_rhythm"><div>In childhood. Surgery may be needed to fuse unstable cervical vertebrae and/or to treat progressive kyphoscoliosis that compromises lung function in AD; corrective osteotomies may be required to treat progressive varus deformity associated with ligament laxity in the knees. Pubertal maturation may be delayed and may require hormonal induction.</div></li><li class="half_rhythm"><div>For those with immunodeficiency. Treatment of underlying infections based on their type, location, and severity; immediate antiviral treatment with intravenous high-dose acyclovir for varicella; consideration of prophylactic antibiotic therapy and/or immunoglobulin replacement therapy; physiotherapy and acute and long-term medical management for bronchiectasis. Recurrent severe infections and/or the presence of severe combined immunodeficiency (SCID) and/or severely depressed erythropoiesis may warrant bone marrow transplantation.</div></li><li class="half_rhythm"><div>Malignancies. Treat in the usual manner.</div></li></ul><p><i>Prevention of secondary complications:</i> If cervical spinal instability is identified in a person with AD, special care is required during general anesthesia.</p><p><i>Surveillance:</i></p><ul><li class="half_rhythm"><div>Skeletal dysplasia. Clinical and (if warranted) radiographic monitoring of growth, joints of the lower extremities, and spine annually in childhood and as required in adulthood. Individuals with AD require annual clinical and radiographic monitoring of the spine.</div></li><li class="half_rhythm"><div>Anemia. For those who have not had anemia, observe for clinical signs of anemia; for those in remission after treatment, monitor for evidence of relapse.</div></li><li class="half_rhythm"><div>Immunodeficiency/infection. Monitor all children regardless of immune status during the first two years of life for recurrent infections, especially life-threatening varicella. Annual evaluation after age two years. High-resolution CT examination for those with features suggestive of bronchiectasis.</div></li><li class="half_rhythm"><div>Malignancies. No specific recommendations exist; regular examination for evidence of lymphomas, basal cell carcinomas, and other associated malignancies is advised.</div></li><li class="half_rhythm"><div>Endocrinology. Monitor pubertal maturation.</div></li></ul><p><i>Agents/circumstances to avoid:</i> Administration of live vaccines when signs of abnormal immunologic function or SCID are present.</p><p><i>Evaluation of relatives at risk:</i> Early diagnosis of relatives at risk for the CHH-AD spectrum allows for early management of manifestations that can be associated with significant morbidity (e.g., infections, immunization with live vaccines, malignancies).</p></div><div><h4 class="inline">Genetic counseling.</h4><p>The CHH-AD spectrum is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants in the family have been identified.</p></div></div><div id="chh.GeneReview_Scope"><h2 id="_chh_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="chh.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK84550/table/chh.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chh.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chh.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Cartilage-Hair Hypoplasia &#x02013; Anauxetic Dysplasia Spectrum Disorders: Included Phenotypes</th></tr></thead><tbody><tr><td headers="hd_h_chh.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Cartilage-hair hypoplasia (CHH)</div></li><li class="half_rhythm"><div>Metaphyseal dysplasia without hypotrichosis (MDWH)</div></li><li class="half_rhythm"><div>Anauxetic dysplasia (AD)</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#chh.Nomenclature">Nomenclature</a>.</p></div></dd></dl></div></div></div></div><div id="chh.Diagnosis"><h2 id="_chh_Diagnosis_">Diagnosis</h2><p>There are no formal diagnostic criteria for CHH, as individuals present with highly variable phenotypes.</p><p>The cartilage-hair hypoplasia &#x02013; anauxetic dysplasia (CHH-AD) spectrum disorders are a continuum ranging from short stature without hypotrichosis with only radiographic evidence of metaphyseal dysplasia (MDWH) [<a class="bk_pop" href="#chh.REF.bonaf_.2002.146">Bonaf&#x000e9; et al 2002</a>] to short stature with hypotrichosis and variable metaphyseal dysplasia of the tubular bones (CHH) [<a class="bk_pop" href="#chh.REF.mckusick.1965.285">McKusick et al 1965</a>, <a class="bk_pop" href="#chh.REF.m_kitie.1993.211">M&#x000e4;kitie &#x00026; Kaitila 1993</a>] to severe deforming short stature with metaphyseal, epiphyseal, and vertebral dysplasia (anauxetic dysplasia [AD]) [<a class="bk_pop" href="#chh.REF.horn.2001.262">Horn et al 2001</a>, <a class="bk_pop" href="#chh.REF.thiel.2005.795">Thiel et al 2005</a>].</p><p>Newborn screening for severe combined immunodeficiency using detection of T-cell receptor excision circles is able to identify some of the individuals with CHH prior to recognition of other findings [<a class="bk_pop" href="#chh.REF.kwan.2013.140">Kwan et al 2013</a>].</p><div id="chh.Suggestive_Findings"><h3>Suggestive Findings</h3><p>CHH-AD spectrum disorders <b>should be suspected</b> in individuals with:</p><ul><li class="half_rhythm"><div>Mild to severe disproportionate short-limbed short stature (final adult height &#x0003c;85-151 cm)</div></li><li class="half_rhythm"><div>Presence of variable metaphyseal dysplasia with epiphyseal and vertebral dysplasia in the severe end of the spectrum</div></li></ul><p>Especially when accompanied by:</p><ul><li class="half_rhythm"><div>Short tubular bones</div></li><li class="half_rhythm"><div>Bowed femora and tibiae</div></li><li class="half_rhythm"><div>"Bullet"-shaped middle phalanges, cone-shaped epiphyses, and premature epiphyseal fusion on hand radiographs</div></li><li class="half_rhythm"><div>Laxity of ligaments with joint hypermobility, but limited extension of the elbows</div></li><li class="half_rhythm"><div>Fine, silky hair</div></li><li class="half_rhythm"><div>Increased rate of infections or intestinal dysfunction or anemia</div></li></ul><div id="chh.Clinical_Findings_by_Phenotype"><h4>Clinical Findings by Phenotype</h4><p><b>Cartilage-hair hypoplasia (CHH)</b></p><ul><li class="half_rhythm"><div>Disproportionate short-limb short stature (present in 100% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> adults; prenatal onset in 76%-93%)</div></li><li class="half_rhythm"><div>Short fingers and toes</div></li><li class="half_rhythm"><div>Bowed femora and tibiae (present in 77%)</div></li><li class="half_rhythm"><div>Laxity of ligaments with hypermobility of joints (in 87%)</div></li><li class="half_rhythm"><div>Limited extension of the elbows (83%)</div></li><li class="half_rhythm"><div>Lumbar lordosis, chest deformity (~50%)</div></li><li class="half_rhythm"><div>Blonde, sparse, fine silky hair (89%-93%)</div></li><li class="half_rhythm"><div>Impaired lymphocyte proliferation and T-lymphocyte function (88%) with increased rate of:</div><ul><li class="half_rhythm"><div>Infections in infancy and childhood (35%-65%)</div></li><li class="half_rhythm"><div>Severe varicella infection (11%)</div></li><li class="half_rhythm"><div>Severe combined immunodeficiency</div></li><li class="half_rhythm"><div>Bronchiectasis (29%) [<a class="bk_pop" href="#chh.REF.kostjukovits.2017a.375">Kostjukovits et al 2017a</a>]</div></li></ul></li><li class="half_rhythm"><div>Macrocytic, hypoplastic anemia in early childhood (79%)</div></li><li class="half_rhythm"><div>Lymphomas; leukemia; neoplasms of the skin, eye, and liver (6%-11%)</div></li><li class="half_rhythm"><div>Congenital megacolon or Hirschsprung disease (7%-8%)</div></li><li class="half_rhythm"><div>Intestinal malabsorption with diarrhea and failure to thrive</div></li><li class="half_rhythm"><div>Cutaneous and visceral granulomas [<a class="bk_pop" href="#chh.REF.moshous.2011.847">Moshous et al 2011</a>, <a class="bk_pop" href="#chh.REF.mccann.2014.42">McCann et al 2014</a>]</div></li></ul><p><b>Metaphyseal dysplasia without hypotrichosis (MDWH)</b></p><ul><li class="half_rhythm"><div>Clinical features similar to CHH, but with normal hair</div></li><li class="half_rhythm"><div>Absence of immunodeficiency, anemia, and intestinal manifestations</div></li></ul><p><b>Anauxetic dysplasia (AD)</b></p><ul><li class="half_rhythm"><div>Prenatal onset of extreme short-limb short stature (100%)</div></li><li class="half_rhythm"><div>Barrel chest with hyperlordosis and kyphoscoliosis</div></li><li class="half_rhythm"><div>Dislocated hips</div></li><li class="half_rhythm"><div>Atlantoaxial subluxation leading to cervical spine compression</div></li><li class="half_rhythm"><div>Facial features. Midfacial hypoplasia and macroglossia</div></li><li class="half_rhythm"><div>Dental abnormalities</div></li><li class="half_rhythm"><div>Mild intellectual disability</div></li></ul></div><div id="chh.Radiographic_Findings_by_Phenotype"><h4>Radiographic Findings by Phenotype</h4><p>Note: Radiographic findings tend to be highly variable.</p><p><b>Cartilage-hair hypoplasia (CHH)</b></p><ul><li class="half_rhythm"><div>Short and thick tubular bones</div></li><li class="half_rhythm"><div>Short and bullet-shaped metacarpals and phalanges with cone-shaped epiphyses</div></li><li class="half_rhythm"><div>Metaphyseal dysplasia of all tubular bones, most prominent changes at the knees</div></li><li class="half_rhythm"><div>Distal metaphyses. Wide, flared, occasionally scalloped with cystic areas; poor ossification with trabeculation</div></li><li class="half_rhythm"><div>Epiphyseal changes. Absent or mild in the femoral head</div></li><li class="half_rhythm"><div>Vertebral bodies. Normal or mild biconvexity with increased height, lumbar lordosis, reduced widening of interpediculate distance in the lumbar spine</div></li></ul><p><b>Metaphyseal dysplasia without hypotrichosis (MDWH).</b> Similar to those in CHH</p><p><b>Anauxetic dysplasia (AD)</b></p><ul><li class="half_rhythm"><div>Vertebral bodies. Late-maturing ovoid with concave dorsal surfaces in the lumbar region; dislocation in the cervical spine</div></li><li class="half_rhythm"><div>Femora. Small capital femoral epiphyses with hypoplastic femoral necks</div></li><li class="half_rhythm"><div>Iliac bodies. Hypoplastic</div></li><li class="half_rhythm"><div>Acetabulae. Shallow</div></li><li class="half_rhythm"><div>Metacarpals. Short with widened shafts (I and V)</div></li><li class="half_rhythm"><div>Phalanges. Very short and broad with small, late ossifying epiphyses and bullet-shaped middle phalanges</div></li></ul></div></div><div id="chh.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of cartilage-hair hypoplasia &#x02013; anauxetic dysplasia (CHH-AD) <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the above <a href="#chh.Suggestive_Findings">Suggestive Findings</a> including clinical and characteristic radiographic findings. If clinical and radiographic findings are inconclusive, identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>RMRP</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK84550/table/chh.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figchhTmoleculargenetictestingusedin" rid-ob="figobchhTmoleculargenetictestingusedin">Table 1</a>) can confirm the diagnosis and allow for family studies.</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of CHH-AD is broad, individuals with the distinctive findings described in <a href="#chh.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#chh.Option_1">Option 1</a>), whereas those with a phenotype indistinguishable from many other inherited disorders with short stature and/or immune deficiency are more likely to be diagnosed using genomic testing (see <a href="#chh.Option_2">Option 2</a>).</p><div id="chh.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of CHH-AD <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>RMRP</i> detects nucleotide variants and small intragenic deletions/insertions/duplications; typically, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. Sequence analysis should cover both the transcribed region and the <a class="def" href="/books/n/gene/glossary/def-item/promoter-region/">promoter region</a>. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div><div class="half_rhythm">Targeted analysis for the common <a class="figpopup" href="/books/NBK84550/table/chh.T.rmrp_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figchhTrmrppathogenicvariantsdiscussed" rid-ob="figobchhTrmrppathogenicvariantsdiscussed">g.70A&#x0003e;G</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> can be performed first in individuals of Finnish or Amish ancestry.</div><div class="half_rhythm">Note: This noncoding RNA spans only 268 bp; therefore, targeted testing by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> is likely to result in analysis of the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>RMRP</i> and other genes of interest (see <a href="#chh.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="chh.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders characterized by short stature, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used, but <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible; however, regardless of the method, <i>RMRP</i> pathogenic variants may not be detected because <i>RMRP</i> is a small (268-bp) untranslated gene without introns and exons. Note that although <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is defined traditionally as the sequence encompassing all exons of protein-coding genes in the genome it also may be extended to target functional non-protein-coding elements such as RMRP.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="chh.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Cartilage-Hair Hypoplasia &#x02013; Anauxetic Dysplasia Spectrum Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK84550/table/chh.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chh.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chh.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_chh.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_chh.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_chh.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>RMRP</i></td><td headers="hd_h_chh.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_chh.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_chh.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_chh.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="chh.TF.1.1"><p class="no_margin">See <a href="/books/NBK84550/#chh.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="chh.TF.1.2"><p class="no_margin">See <a href="#chh.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="chh.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include nucleotide substitution and small intragenic deletions. Typically, whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="chh.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#chh.REF.martin.2007.219">Martin &#x00026; Li [2007]</a></p></div></dd><dt>5. </dt><dd><div id="chh.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="chh.TF.1.6"><p class="no_margin">To date, no large deletions or duplications involving <i>RMRP</i> have been reported to cause cartilage-hair hypoplasia &#x02013; anauxetic dysplasia spectrum disorders [<a class="bk_pop" href="#chh.REF.ridanp__.2001.195">Ridanp&#x000e4;&#x000e4; et al 2001</a>, <a class="bk_pop" href="#chh.REF.thiel.2011.131">Thiel &#x00026; Rauch 2011</a>].</p></div></dd></dl></div></div></div></div></div></div><div id="chh.Clinical_Characteristics"><h2 id="_chh_Clinical_Characteristics_">Clinical Characteristics</h2><div id="chh.Clinical_Description"><h3>Clinical Description</h3><p>Cartilage-hair hypoplasia &#x02013; anauxetic dysplasia (CHH-AD) spectrum disorders are a continuum that includes three phenotypes:</p><ul><li class="half_rhythm"><div>Metaphyseal dysplasia without hypotrichosis (MDWH);</div></li><li class="half_rhythm"><div>CHH, with metaphyseal dysplasia and hypotrichosis; and</div></li><li class="half_rhythm"><div>At the severe end, the rare anauxetic dysplasia (AD), with the most pronounced skeletal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</div></li></ul><p>The mechanisms for phenotypic variability are incompletely understood (see <a href="#chh.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>).</p><p><b>Disproportionate short-limb short stature</b> is the hallmark finding and is usually recognized in the newborn and occasionally prenatally. Proportionate short stature has been observed in some individuals [<a class="bk_pop" href="#chh.REF.van_der_burgt.1991.371">van der Burgt et al 1991</a>, <a class="bk_pop" href="#chh.REF.m_kitie.1993.211">M&#x000e4;kitie &#x00026; Kaitila 1993</a>]. Normal growth in childhood has also been reported [<a class="bk_pop" href="#chh.REF.klemetti.2017.204">Klemetti et al 2017</a>]. Growth failure is progressive and associated with the degree of disproportion. Lumbar lordosis and scoliosis may contribute to the short stature.</p><p>Marked inter- and <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> of short stature has been observed. Growth curves for Finnish individuals with CHH have been published. Final adult height ranges from 104 to 151 cm in CHH (median: 131 cm in males; 122 cm in females) and less than 85 cm in AD [<a class="bk_pop" href="#chh.REF.m_kitie.1992a.176">M&#x000e4;kitie et al 1992a</a>, <a class="bk_pop" href="#chh.REF.m_kitie.1993.211">M&#x000e4;kitie &#x00026; Kaitila 1993</a>, <a class="bk_pop" href="#chh.REF.horn.2001.262">Horn et al 2001</a>].</p><p><b>Laxity of ligaments</b> with joint hypermobility is marked especially in the hands and feet. The laxity of lateral ligaments of the knees contributes to the varus deformity of the lower extremities.</p><p><b>Fine silky hair.</b> Sparse hair, reduction of the diameter of the hair shaft, and loss of the central pigmented core of the hair shaft contribute to the distinctive appearance of the hair. About 15% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons have complete primary alopecia including scalp hair and eyelashes, eyebrows, and body hair.</p><p><b>Immunodeficiency</b> may manifest as lymphopenia and defects in T-lymphocyte function and/or proliferation [<a class="bk_pop" href="#chh.REF.kavadas.2008.1178">Kavadas et al 2008</a>]. Sometimes defects in B-lymphocyte proliferation with low IgG and undetectable IgA are observed. Although deficient cellular immunity is present in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (88%), an increased rate of infection is noted in only 35%-65%, usually during infancy and childhood. Early reports on fatal varicella infection conflict with the more recent publications on larger cohorts of individuals with CHH with mostly uncomplicated varicella disease [<a class="bk_pop" href="#chh.REF.m_kitie.1998.816">M&#x000e4;kitie et al 1998</a>]. Severe respiratory disease (e.g., lymphoplasmacytic bronchiolitis) has been reported in children [<a class="bk_pop" href="#chh.REF.baillybotuha.2008.429">Bailly-Botuha et al 2008</a>]. Chronic viral infections with bocavirus and norovirus have been reported [<a class="bk_pop" href="#chh.REF.kainulainen.2014.256">Kainulainen et al 2014</a>]. Impaired cellular immunity persists into adulthood. Individuals with CHH and combined immunodeficiency are at particular risk for chronic bronchiectasis [<a class="bk_pop" href="#chh.REF.toiviainensalo.2008.422">Toiviainen-Salo et al 2008</a>], which may, however, develop even in individuals with mild immunodeficiency [<a class="bk_pop" href="#chh.REF.kostjukovits.2017a.375">Kostjukovits et al 2017a</a>]. Fatal enteroviral meningoencephalitis has been reported in a child with CHH [<a class="bk_pop" href="#chh.REF.vatanavicharn.2010.523">Vatanavicharn et al 2010</a>].</p><p><b>Autoimmune complications.</b> In rare instances autoimmune complications and a form of severe allergic reaction have been observed in CHH; however, the pathophysiology is still unknown [<a class="bk_pop" href="#chh.REF.bacchetta.2009.2449">Bacchetta et al 2009</a>, <a class="bk_pop" href="#chh.REF.narra.2009.1418">Narra &#x00026; Shearer 2009</a>]. Cutaneous and visceral granulomatous inflammatory lesions have been described in five individuals with CHH [<a class="bk_pop" href="#chh.REF.moshous.2011.847">Moshous et al 2011</a>, <a class="bk_pop" href="#chh.REF.mccann.2014.42">McCann et al 2014</a>]. Individuals with CHH demonstrate broad autoantibody reactivity compared to healthy controls [<a class="bk_pop" href="#chh.REF.biggs.2017.508">Biggs et al 2017</a>].</p><p><b>Anemia.</b> Deficient erythropoiesis may lead to mild to severe macrocytic anemia. Mild anemia is seen in about 80% of those with CHH and resolves spontaneously in childhood in most cases [<a class="bk_pop" href="#chh.REF.m_kitie.1992b.1026">M&#x000e4;kitie et al 1992b</a>]. Severe and persistent anemia resembling that of <a href="/books/n/gene/diamond-b/">Diamond-Blackfan syndrome</a> is seen in about 6% [<a class="bk_pop" href="#chh.REF.williams.2005.35">Williams et al 2005</a>]. About 50%-75% of those with severe anemia require lifelong transfusions or bone marrow transplantation (see <a href="#chh.Management">Management</a>); on occasion spontaneous resolution is observed [<a class="bk_pop" href="#chh.REF.williams.2005.35">Williams et al 2005</a>].</p><p><b>Malignancies.</b> Extended follow up of persons with CHH revealed that about 11% of the cohort (14/123) followed for 39 years had developed malignancies [<a class="bk_pop" href="#chh.REF.taskinen.2008.2370">Taskinen et al 2008</a>]. Kaplan-Meier estimate gave a probability of a cancer event (excluding basal cell carcinoma) of 41% by age 65 years.</p><p>Nine of the 14 malignancies were diagnosed in persons age 15-44 years. Of the 14 who developed malignancies, nine have died; median time to death was three months after initial diagnosis of the malignancy. Underlying pathogenic variants in <i>RMRP</i> and severity of preceding immunodeficiency varied and did not correlate with risk of malignancy.</p><p>The most frequently observed cancers are non-Hodgkin lymphoma, followed by squamous cell carcinoma, leukemia, and Hodgkin lymphoma; non-aggressive basal cell carcinoma was also common. There are isolated reports of uterine carcinoma and vocal cord carcinoma [<a class="bk_pop" href="#chh.REF.kostjukovits.2017b.612">Kostjukovits et al 2017b</a>]. Rarely, two or more malignancies are observed in one individual.</p><p><b>Intestinal problems</b></p><ul><li class="half_rhythm"><div><b>Newborn period.</b> Hirschsprung disease with short-segment or total colon aganglionosis is observed in 7%-8% of those with CHH, especially infants with the severe forms of CHH [<a class="bk_pop" href="#chh.REF.m_kitie.2001a.929">M&#x000e4;kitie et al 2001a</a>].</div></li><li class="half_rhythm"><div><b>Infancy.</b> When Hirschsprung disease has been excluded, malabsorption secondary to gastrointestinal infections can occur in the first two years of life [<a class="bk_pop" href="#chh.REF.m_kitie.1995.39">M&#x000e4;kitie et al 1995</a>]. The main findings are "celiac syndrome" with diarrhea and failure to thrive. Although most intestinal manifestations occur in the first two years of life, they can occur later in childhood. Intestinal problems have not been described in AD or MDWH.</div></li></ul><p><b>Impaired spermatogenesis.</b> Because of a defect in cell proliferation, males with CHH have defects in sperm concentration, motility, morphology, and immunology [<a class="bk_pop" href="#chh.REF.m_kitie.2001b.201">M&#x000e4;kitie et al 2001b</a>]. Testicles are smaller than normal for age and pubertal status; however, serum concentrations of testosterone, inhibin B, and gonadotropins are within the normal range in most individuals.</p><p><b>Delayed puberty.</b> Girls with CHH may have hypogonadotropic or normogonadotropic hypogonadism with no spontaneous pubertal development [<a class="bk_pop" href="#chh.REF.holopainen.2018.422">Holopainen et al 2018</a>].</p><p><b>Additional findings</b> observed in some persons with AD [<a class="bk_pop" href="#chh.REF.horn.2001.262">Horn et al 2001</a>]:</p><ul><li class="half_rhythm"><div>Atlantoaxial subluxation with fatal cervical compression</div></li><li class="half_rhythm"><div>Mild intellectual disability</div></li></ul></div><div id="chh.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>The CHH-AD spectrum includes a range of phenotypes. <i>RMRP</i> is not translated into a protein; thus, <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation depends on the position of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the transcript and the proposed effect on transcript folding and RNA/protein interaction (see <a href="#chh.Molecular_Genetics">Molecular Genetics</a>).</p><p>The milder phenotypes are usually caused by either of the following:</p><ul><li class="half_rhythm"><div>Compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic variants within the transcript resulting in little to intermediate effect on function of the RNase MRP (complex formed of the RMRP transcript and other proteins)</div></li><li class="half_rhythm"><div>Compound heterozygosity for one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> within the transcript and one pathogenic variant in the <a class="def" href="/books/n/gene/glossary/def-item/promoter-region/">promoter region</a></div></li></ul><p>AD is caused by either of the following:</p><ul><li class="half_rhythm"><div>Compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants that severely alter function OR</div></li><li class="half_rhythm"><div>Compound heterozygosity for:</div><ul><li class="half_rhythm"><div>One <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> within the transcript that severely alters the RNase MRP function AND</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> (reduced function) <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> (e.g., <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> leading to an unstable transcript)</div></li></ul></li></ul></div><div id="chh.Nomenclature"><h3>Nomenclature</h3><p>Cartilage hair hypoplasia (CHH) or metaphyseal chondrodysplasia, McKusick type was first described in the Old Order Amish population by McKusick and his colleagues [<a class="bk_pop" href="#chh.REF.mckusick.1965.285">McKusick et al 1965</a>].</p><p>Individuals with normal hair and metaphyseal dysplasia, called metaphyseal dysplasia without hypotrichosis (MDWH), were reported by <a class="bk_pop" href="#chh.REF.bonaf_.2002.146">Bonaf&#x000e9; et al [2002]</a>.</p><p>Anauxetic dysplasia was named after the Greek "not to permit growth" [<a class="bk_pop" href="#chh.REF.horn.2001.262">Horn et al 2001</a>].</p></div><div id="chh.Prevalence"><h3>Prevalence</h3><p>About 700 individuals are currently known to have a CHH-AD spectrum disorder [Kaitila, personal communication]. The most severe form, AD, is extremely rare: fewer than ten <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been reported.</p><p>Affected individuals have been reported in most populations; however, a high incidence of CHH was noted in the Old Order Amish population with a prevalence of 1:1,000-2:1,000 (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency 1:10) and in Finland with an incidence of 1:23,000 (carrier frequency 1:76) [<a class="bk_pop" href="#chh.REF.m_kitie.1992.652">M&#x000e4;kitie 1992</a>, <a class="bk_pop" href="#chh.REF.m_kitie.1993.211">M&#x000e4;kitie &#x00026; Kaitila 1993</a>].</p></div></div><div id="chh.Genetically_Related_Allelic_Disorder"><h2 id="_chh_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>Single individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>RMRP</i> pathogenic variants and immunodeficiency without skeletal features [<a class="bk_pop" href="#chh.REF.ip.2015.147">Ip et al 2015</a>] and with Omenn syndrome [<a class="bk_pop" href="#chh.REF.roifman.2006.897">Roifman et al 2006</a>] and normal childhood growth [<a class="bk_pop" href="#chh.REF.klemetti.2017.204">Klemetti et al 2017</a>] have been described.</p></div><div id="chh.Differential_Diagnosis"><h2 id="_chh_Differential_Diagnosis_">Differential Diagnosis</h2><div id="chh.T.disorders_to_consider_in_the_diffe" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Cartilage-Hair Hypoplasia &#x02013; Anauxetic Dysplasia (CHH-AD) Spectrum Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK84550/table/chh.T.disorders_to_consider_in_the_diffe/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chh.T.disorders_to_consider_in_the_diffe_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_1" style="text-align:left;vertical-align:middle;">Differential<br />Diagnosis<br />Disorder</th><th id="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features</th></tr><tr><th headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4" id="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping</th><th headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4" id="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing</th></tr></thead><tbody><tr><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/schmid-mcd/">Schmid dysplasia</a></td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL10A1</i></td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Short stature &#x00026; radiographic metaphyseal abnormalities (metaphyseal dysplasia especially in proximal femur) resembling CHH</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In Schmid dysplasia: no extraskeletal manifestations</td></tr><tr><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Jansen dysplasia<br />(OMIM <a href="http://omim.org/entry/156400" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">156400</a>)</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PTH1R</i></td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Short stature &#x00026; radiographic metaphyseal abnormalities resembling CHH</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In Jansen dysplasia: hypercalcemia &#x00026; hypercalciuria&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sds/">Shwachman-Diamond syndrome</a> (SDS)</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SBDS</i></td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Short stature &#x00026; radiographic metaphyseal abnormalities resembling CHH</div></li><li class="half_rhythm"><div>Increased infections</div></li><li class="half_rhythm"><div>Anemia</div></li></ul>
</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In SDS:
<ul><li class="half_rhythm"><div>Milder skeletal features (usually)</div></li><li class="half_rhythm"><div>Principal manifestations: exocrine pancreatic insufficiency, neutropenia, &#x00026; failure to thrive&#x000a0;<sup>2</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/siod/">Schimke immunoosseous dysplasia</a> (SIOD)</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMARCAL1</i></td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Cellular immune deficiency&#x000a0;<sup>3</sup></div></li></ul>
</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In SIOD:
<ul><li class="half_rhythm"><div>Short stature caused by short trunk (vs short-limbed short stature in CHH-AD)</div></li><li class="half_rhythm"><div>Characteristic facies</div></li><li class="half_rhythm"><div>Vascular problems</div></li></ul>
</td></tr><tr><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Combined immunodeficiency syndromes</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 4</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR<br />XL</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Immunodeficiency</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In most immunodeficiency syndromes: no skeletal abnormalities</td></tr><tr><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Omenn syndrome<br />(OMIM <a href="http://omim.org/entry/603554" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">603554</a>)</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RAG1</i><br /><i>RAG2</i><br /><i>DCLRE1C</i></td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Hematologic changes</div></li><li class="half_rhythm"><div>Immunologic changes</div></li></ul>
</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Omenn syndrome is more severe &#x00026; includes:
<ul><li class="half_rhythm"><div>Ichthyosiform skin changes</div></li><li class="half_rhythm"><div>Septicemia</div></li></ul>
</td></tr><tr><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Isolated<br />(see <a href="/books/n/gene/cyclic-n/"><i>ELANE</i>-Related Neutropenia</a>)</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 5</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR<br />XL</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Congenital neutropenia</td><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Skeletal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in CHH</td></tr><tr><td headers="hd_h_chh.T.disorders_to_consider_in_the_diffe_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Syndromic&#x000a0;<sup>6</sup><br />(see <a href="/books/n/gene/was/"><i>WAS</i>-Related Disorders</a>; <a href="/books/n/gene/g6pc3-def/">G6PC3 Deficiency</a>)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="chh.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#chh.REF.savoldi.2013.2614">Savoldi et al [2013]</a></p></div></dd><dt>2. </dt><dd><div id="chh.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#chh.REF.levin.2015.1066">Levin et al [2015]</a></p></div></dd><dt>3. </dt><dd><div id="chh.TF.2.3"><p class="no_margin">If recurrent infections are present, milder forms of SIOD may be confused w/CHH [<a class="bk_pop" href="#chh.REF.baradaranheravi.2008.2013">Baradaran-Heravi et al 2008</a>].</p></div></dd><dt>4. </dt><dd><div id="chh.TF.2.4"><p class="no_margin">See OMIM Phenotypic series: <a href="https://omim.org/phenotypicSeries/PS300755" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Immunodeficiency (Select Examples) - PS300755</a> for genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p></div></dd><dt>5. </dt><dd><div id="chh.TF.2.5"><p class="no_margin">See OMIM Phenotypic series: <a href="https://omim.org/phenotypicSeries/PS202700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Neutropenia, severe congenital - PS202700</a> for genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p></div></dd><dt>6. </dt><dd><div id="chh.TF.2.6"><p class="no_margin">Congenital neutropenia that occurs as part of a syndrome can be caused by pathogenic variants affecting glucose metabolism or lysosomal function.</p></div></dd></dl></div></div></div></div><div id="chh.Management"><h2 id="_chh_Management_">Management</h2><div id="chh.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with a cartilage-hair hypoplasia &#x02013; anauxetic dysplasia (CHH-AD) spectrum disorder, the evaluations summarized in <a class="figpopup" href="/books/NBK84550/table/chh.T.recommended_evaluations_following/?report=objectonly" target="object" rid-figpopup="figchhTrecommendedevaluationsfollowing" rid-ob="figobchhTrecommendedevaluationsfollowing">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><div id="chh.T.recommended_evaluations_following" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with CHH-AD Spectrum Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK84550/table/chh.T.recommended_evaluations_following/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chh.T.recommended_evaluations_following_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chh.T.recommended_evaluations_following_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_chh.T.recommended_evaluations_following_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_chh.T.recommended_evaluations_following_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pulmonary consultation</td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation for evidence of respiratory disease</td></tr><tr><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal/</b><br /><b>Feeding</b></td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gastroenterologic consultation</td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> megacolon if clinical observation is suggestive</td></tr><tr><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Full skeletal survey</td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To include (in AD) views of cervical spine to identify cervical vertebral abnormalities &#x00026; to assess risk for atlantoaxial subluxation</td></tr><tr><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Orthopedic consultation</td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation for complications of joint laxity, lumbar lordosis, chest deformity, scoliosis, &#x00026; varus deformity of lower extremities</td></tr><tr><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hematologic/</b><br /><b>Lymphatic</b></td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complete blood count w/differential cell count</td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation for macrocytic anemia &#x00026; immunodeficiency&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Hematologic consultation</td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If blood count is abnormal, for further assessment &#x00026; treatment</td></tr><tr><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Allergic/</b><br /><b>Immunologic</b></td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Laboratory evaluations for immunodeficiency&#x000a0;<sup>1</sup></td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl:
<ul><li class="half_rhythm"><div>Serum concentration IgG, IgA, IgM, &#x00026; IgG subclasses</div></li><li class="half_rhythm"><div>CD3, 4, 8, 19, 16/56</div></li><li class="half_rhythm"><div>Post-vaccine titers</div></li><li class="half_rhythm"><div>Other immunologic parameters:</div><ul><li class="half_rhythm"><div>Allogeneic lymphocyte cytotoxicity</div></li><li class="half_rhythm"><div>TREC analysis</div></li><li class="half_rhythm"><div>T-cell repertoire</div></li><li class="half_rhythm"><div>Proliferation response to PHA</div></li><li class="half_rhythm"><div>Proliferation response to anti-CD3</div></li></ul></li></ul>
</td></tr><tr><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Immunologic consultation</td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If immunologic testing is abnormal or if child has infections, for assessment &#x00026; treatment &#x00026; to determine vaccination program &#x00026; approach to varicella prophylaxis</td></tr><tr><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_chh.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = anauxetic dysplasia; TREC = T-cell receptor excision circles</p></div></dd><dt>1. </dt><dd><div id="chh.TF.3.1"><p class="no_margin"><a class="bk_pop" href="#chh.REF.rider.2009.119">Rider et al [2009]</a></p></div></dd></dl></div></div></div></div><div id="chh.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Skeletal dysplasia</b></p><ul><li class="half_rhythm"><div>Corrective osteotomies may be warranted in late childhood or adolescence for excessive varus deformity of the lower extremities [<a class="bk_pop" href="#chh.REF.riley.2015.145">Riley et al 2015</a>].</div></li><li class="half_rhythm"><div>In persons with AD, surgery may be needed to fuse malformed cervical vertebrae in infancy and to correct or prevent the progression of kyphoscoliosis.</div></li><li class="half_rhythm"><div>Orthopedic surgery may be complicated by low bone density.</div></li></ul><p><b>Short stature.</b> Treatment with recombinant growth hormone has not shown any sustained benefit in individuals with CHH and cannot be recommended [<a class="bk_pop" href="#chh.REF.obaramoszynska.2013.e162">Obara-Moszynska et al 2013</a>].</p><p><b>Immunodeficiency and infection.</b> The treatment of infections in individuals with immunodeficiency is based on their type, location, and severity.</p><ul><li class="half_rhythm"><div>Immediate antiviral treatment with intravenous high-dose acyclovir must be considered at the first symptoms of varicella infection to prevent complications.</div></li><li class="half_rhythm"><div>Consider prophylactic antibiotic therapy if the individual has recurrent infections or if neutropenia/severe lymphopenia is present. Consider also immunoglobulin replacement therapy if immunoglobulin or IgG subclass levels are low, or if vaccine responses are inadequate.</div></li><li class="half_rhythm"><div>Individuals with bronchiectasis need proper management of infectious exacerbations and physiotherapy. Consider also long-term treatment with inhaled antibiotics or oral macrolide [<a class="bk_pop" href="#chh.REF.altenburg.2015.147">Altenburg et al 2015</a>].</div></li><li class="half_rhythm"><div>Recurrent severe infections and/or the presence of severe combined immunodeficiency (SCID) may warrant bone marrow transplantation / hematopoietic stem cell transplantation (HSCT) [<a class="bk_pop" href="#chh.REF.guggenheim.2006.751">Guggenheim et al 2006</a>]. HSCT has resulted in normalization of T-lymphocyte numbers and function, resolution of autoimmune manifestations, and catch-up growth, probably due to reduced infections. Overall survival rates have been reported at 63% for unrelated donor transplants and as high as 80% for matched sibs. HSCT should be considered in selected individuals with CHH with recurrent infections and autoimmune manifestations or bone marrow dysplasia for whom a well-matched donor is available [<a class="bk_pop" href="#chh.REF.bordon.2010.27">Bordon et al 2010</a>].</div></li><li class="half_rhythm"><div>Anti-TNFa therapy has been used successfully in the treatment of cutaneous and visceral granulomas. However, fatal progressive multifocal leukoencephalopathy caused by JC virus has been described during treatment with anti-TNFa antibodies. HSCT resulted in disappearance of granulomas in two of three transplanted individuals [<a class="bk_pop" href="#chh.REF.moshous.2011.847">Moshous et al 2011</a>].</div></li></ul><p><b>Anemia</b></p><ul><li class="half_rhythm"><div>Treatment of severe anemia secondary to depressed erythropoiesis may require repeated red cell transfusions in infancy and childhood; lifelong transfusions or bone marrow transplantation are rarely needed [<a class="bk_pop" href="#chh.REF.williams.2005.35">Williams et al 2005</a>]. In individuals requiring repeated transfusions iron chelation is successful and well tolerated when needed [<a class="bk_pop" href="#chh.REF.taskinen.2013.844">Taskinen et al 2013</a>].</div></li><li class="half_rhythm"><div>Although steroid treatment has been effective in treating anemia in some persons with CHH, the available data are not sufficient to recommend this therapy in general, especially considering the potential side effects of immune suppression and growth retardation.</div></li></ul><p><b>Malignancy.</b> No specific recommendations for the treatment of the observed malignancies are available. Non-Hodgkin lymphoma often has a poor prognosis with conventional cytotoxic protocols [<a class="bk_pop" href="#chh.REF.taskinen.2008.2370">Taskinen et al 2008</a>].</p><p><b>Endocrine.</b> Pubertal maturation may be delayed and may require hormonal induction.</p></div><div id="chh.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>If a cervical spine abnormality and/or instability is identified, special care should be exercised when general anesthesia is administered.</p></div><div id="chh.Surveillance"><h3>Surveillance</h3><p><b>Skeletal dysplasia</b></p><ul><li class="half_rhythm"><div>Children with CHH require annual measurement of linear growth and body proportions; comparison with published disease-specific growth curves [<a class="bk_pop" href="#chh.REF.m_kitie.1992a.176">M&#x000e4;kitie et al 1992a</a>] is helpful.</div></li><li class="half_rhythm"><div>Pubertal development should be monitored during annual follow-up visits and hypogonadism excluded if puberty is significantly delayed.</div></li><li class="half_rhythm"><div>Clinical assessment for deformities of the lower extremities and joints is appropriate. Radiographic evaluation and orthopedic consultation is necessary if symptomatic misalignment, restricted knee or hip mobility, or symptomatic joint laxity is present.</div></li><li class="half_rhythm"><div>Individuals with AD require annual clinical and radiographic monitoring of the spine.</div></li></ul><p><b>Immunodeficiency and infection</b></p><ul><li class="half_rhythm"><div>As no clinical parameters predict susceptibility to infection in children, ongoing follow up by physicians with experience in this condition is recommended, including routine physical examination and laboratory testing for early detection of infection.</div></li><li class="half_rhythm"><div>Particularly in the first two years of life, children with normal initial immunologic assessment should be monitored for recurrent infections, especially life-threatening varicella infections [<a class="bk_pop" href="#chh.REF.notarangelo.2008.534">Notarangelo et al 2008</a>, <a class="bk_pop" href="#chh.REF.rider.2009.119">Rider et al 2009</a>].</div></li><li class="half_rhythm"><div>Laboratory markers for immunodeficiency may fluctuate in children with CHH, thus emphasizing the need for regular yearly follow up [<a class="bk_pop" href="#chh.REF.kainulainen.2014.256">Kainulainen et al 2014</a>].</div></li><li class="half_rhythm"><div>Bronchiectasis should be suspected especially in subjects with frequent respiratory tract infections and combined immunodeficiency; high-resolution computed tomography should be used for diagnosis [<a class="bk_pop" href="#chh.REF.toiviainensalo.2008.422">Toiviainen-Salo et al 2008</a>]; lung MR examination is recommended for follow up [<a class="bk_pop" href="#chh.REF.kostjukovits.2017a.375">Kostjukovits et al 2017a</a>].</div></li></ul><p><b>Anemia</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Observe for clinical signs of anemia starting from the time of the initial diagnosis until early adolescence.</div></li><li class="half_rhythm"><div class="half_rhythm">Follow RBC, hematocrit, and hemoglobin levels in those in remission after treatment for anemia at least every six months or when clinical signs of anemia reappear.</div><div class="half_rhythm">Note: (1) No data are available on the likely timing of recurrence of anemia after successful treatment; (2) severe anemia in adolescents and adults with CHH can be the presenting symptom of malignancy and may require extensive investigations with bone marrow evaluation and imaging studies.</div></li></ul><p><b>Malignancy</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Children.</b> Although no specific recommendations exist, it is advised that children be evaluated annually by their pediatrician or primary health care provider for lymphomas and other associated malignancies by careful clinical examination and routine blood tests.</div><div class="half_rhythm">Skin should be inspected for abnormal changes, lymph nodes for enlargement, and abdomen for hepatomegaly, splenomegaly, or other abnormalities. Abdominal ultrasound is recommended at a regular one- to two-year interval, as well as yearly laboratory tests including blood counts with differential, LDH, and uric acid.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Adults.</b> As no clinical parameters predict susceptibility to malignancy in adults, ongoing regular follow up beyond adolescence is recommended, including routine physical examination and laboratory testing for early detection of malignancy, as described above. The frequency of follow-up visits need to be determined on an individual basis.</div></li></ul><p><b>Endocrinology.</b> Monitor pubertal maturation.</p></div><div id="chh.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Routine immunizations with inactivated vaccines are considered safe in persons with CHH. However, immunization with live vaccines should be carefully considered in those with CHH and evidence of abnormal immunologic function, and should be avoided in those with CHH and SCID [<a class="bk_pop" href="#chh.REF.rider.2009.119">Rider et al 2009</a>].</p></div><div id="chh.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Early diagnosis of relatives (i.e., sibs) at risk for CHH-AD spectrum disorders is important for early recognition and management of manifestations that can be associated with significant morbidity (e.g., infections, immunization with live vaccines, malignancies). Relatives at risk should be tested if clinical features, especially short stature, are present; completely asymptomatic individuals need not be tested.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the pathogenic variants in the family are known;</div></li><li class="half_rhythm"><div>Radiographic evaluation and <i>RMRP</i> <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> if the pathogenic variants in the family are not known.</div></li></ul><p>See <a href="#chh.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="chh.Pregnancy_Management"><h3>Pregnancy Management</h3><p>No issues are known; however, experience is limited.</p></div><div id="chh.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Varicella vaccine is being investigated for children with CHH who have not had varicella.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="chh.Genetic_Counseling"><h2 id="_chh_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="chh.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>The cartilage-hair hypoplasia &#x02013; anauxetic dysplasia (CHH-AD) spectrum disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="chh.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>RMRP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>According to previous evaluations, heterozygotes (carriers) are not at increased risk for cancer and are asymptomatic [<a class="bk_pop" href="#chh.REF.m_kitie.1999.315">M&#x000e4;kitie et al 1999</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier; <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> in disease severity has been observed.</div></li><li class="half_rhythm"><div>According to previous evaluations, heterozygotes (carriers) are not at increased risk for cancer and are asymptomatic [<a class="bk_pop" href="#chh.REF.m_kitie.1999.315">M&#x000e4;kitie et al 1999</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Unless an individual with CHH-AD spectrum disorder has children with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual or a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, his/her offspring will be obligate heterozygotes (carriers of an <i>RMRP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents has a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>RMRP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="chh.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk family members requires prior identification of the <i>RMRP</i> pathogenic variants in the family.</p></div><div id="chh.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#chh.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="chh.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>RMRP</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for a CHH-AD spectrum disorder are possible.</p><p><b>Ultrasound examination.</b> Prenatal diagnosis may also be possible through fetal ultrasound studies at 16 to 18 weeks' gestation.</p><p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="chh.Resources"><h2 id="_chh_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>F&#x000f6;reningen f&#x000f6;r Kortvuxna</b></div><div>Annebergsgatan 1A</div><div>Sweden</div><div><b>Email:</b> info@fkv.se</div><div><a href="http://fkv.se/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.fkv.se</a></div></li><li class="half_rhythm"><div><b>Little People of America, Inc. (LPA)</b></div><div>250 El Camino Real</div><div>Suite 201</div><div>Tustin CA 92780</div><div><b>Phone:</b> 888-572-2001 (toll-free); 714-368-3689</div><div><b>Fax:</b> 714-368-3367</div><div><b>Email:</b> info@lpaonline.org</div><div><a href="http://www.lpaonline.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lpaonline.org</a></div></li><li class="half_rhythm"><div><b>Lyhytkasvuiset &#x02013; Kortv&#x000e4;xta Ry</b></div><div>PL 14, 02601 Espoo</div><div>Finland</div><div><b>Email:</b> toimisto@lyhytkasvuiset.fi</div><div><a href="https://www.lyhytkasvuiset.fi" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lyhytkasvuiset.fi</a></div></li><li class="half_rhythm"><div><b>European Society for Immunodeficiencies (ESID) Registry</b></div><div>Dr. Gerhard Kindle</div><div>University Medical Center Freiburg Centre of Chronic Immunodeficiency</div><div>Engesserstr. 4</div><div>79106 Freiburg </div><div>Germany</div><div><b>Phone:</b> 49-761-270-34450</div><div><b>Email:</b> esid-registry@uniklinik-freiburg.de</div><div><a href="http://esid.org/Working-Parties/Registry" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ESID Registry</a></div></li><li class="half_rhythm"><div><b>International Skeletal Dysplasia Registry</b></div><div>UCLA</div><div>615 Charles E. Young Drive</div><div>South Room 410</div><div>Los Angeles CA 90095-7358</div><div><b>Phone:</b> 310-825-8998</div><div><b>Fax:</b> 310-206-5266</div><div><b>Email:</b> Salon@mednet.ucla.edu</div><div><a href="https://www.uclahealth.org/ortho/isdr" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International Skeletal Dysplasia Registry</a></div></li><li class="half_rhythm"><div><b>Skeletal Dysplasia Network, European (ESDN)</b></div><div>Institute of Genetic Medicine</div><div>Newcastle University, International Centre for Life</div><div>Central Parkway</div><div> Newcastle upon Tyne NE1 3BZ</div><div>United Kingdom</div><div><b>Email:</b> info@esdn.org</div><div><a href="http://www.esdn.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.esdn.org</a></div></li></ul></div><div id="chh.Molecular_Genetics"><h2 id="_chh_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="chh.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Cartilage-Hair Hypoplasia - Anauxetic Dysplasia Spectrum Disorders : Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK84550/table/chh.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chh.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_chh.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_chh.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_chh.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_chh.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_chh.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_chh.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6023" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>RMRP</i></a></td><td headers="hd_b_chh.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6023" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9p13<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_chh.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Not applicable</td><td headers="hd_b_chh.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=RMRP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RMRP</a></td><td headers="hd_b_chh.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RMRP[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RMRP</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="chh.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="chh.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Cartilage-Hair Hypoplasia - Anauxetic Dysplasia Spectrum Disorders (<a href="/omim/157660,250250,250460,607095" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK84550/table/chh.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chh.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/157660" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">157660</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MITOCHONDRIAL RNA-PROCESSING ENDORIBONUCLEASE, RNA COMPONENT OF; RMRP</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/250250" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">250250</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CARTILAGE-HAIR HYPOPLASIA; CHH</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/250460" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">250460</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS; MDWH</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607095" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607095</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ANAUXETIC DYSPLASIA 1; ANXD1</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>RMRP</i> is an intronless <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoded by nuclear DNA. The <i>RMRP</i> transcript consists of only 267 bp with a type 3 promoter, a PSE element, and a TATA box, and <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> binding sites upstream of the transcription initiation site. The <i>RMRP</i> RNA transcript is not translated into a protein. For a detailed summary of gene and protein information, see <a href="/books/NBK84550/#chh.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> More than 90 different pathogenic variants have been described [<a class="bk_pop" href="#chh.REF.ridanp__.2001.195">Ridanp&#x000e4;&#x000e4; et al 2001</a>, <a class="bk_pop" href="#chh.REF.bonaf_.2005.e47">Bonaf&#x000e9; et al 2005</a>, <a class="bk_pop" href="#chh.REF.hermanns.2006.2121">Hermanns et al 2006</a>, <a class="bk_pop" href="#chh.REF.martin.2007.219">Martin &#x00026; Li 2007</a>, <a class="bk_pop" href="#chh.REF.thiel.2007.519">Thiel et al 2007</a>, <a class="bk_pop" href="#chh.REF.thiel.2011.131">Thiel &#x00026; Rauch 2011</a>, <a class="bk_pop" href="#chh.REF.cherkaoui_jaouad.2015.77">Cherkaoui Jaouad et al 2015</a>].</p><p>A founder <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (g.70A&#x0003e;G) is present in 100% of Old Order Amish, 92% of Finnish, and 48% of non-Finnish individuals with CHH.</p><p>Occasionally small insertions, duplications, or triplications in the <a class="def" href="/books/n/gene/glossary/def-item/promoter-region/">promoter region</a> increase the distance between regulatory elements (i.e., the TATA box and the transcription start site). An increase of 24 to 26 bps between the regulatory elements leads to promoter inefficiency and reduced <i>RMRP</i> transcript levels [<a class="bk_pop" href="#chh.REF.ridanp__.2001.195">Ridanp&#x000e4;&#x000e4; et al 2001</a>, <a class="bk_pop" href="#chh.REF.nakashima.2007.2675">Nakashima et al 2007</a>]. Such variants have been observed in compound heterozygosity with pathogenic variants within the transcript.</p><p>Most pathogenic variants are in conserved regions of the <i>RMRP</i> RNA transcript. Pathogenic variants within the transcribed region affect either (1) evolutionary highly conserved nucleotides that are likely to alter the secondary structure through mispairing in stem regions; or (2) RNA/protein interaction forming the RNase MRP complex.</p><p>The position of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the <i>RMRP</i> transcript and the proposed effect on transcript folding and RNA/protein interaction results in variable phenotypes in the CHH-AD spectrum (see <a href="#chh.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>).</p><p>Interestingly, <i>RMRP</i> pathogenic variants may affect both <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> and rRNA cleavage and thus cell-cycle regulation and protein synthesis (see <a class="bk_pop" href="#chh.REF.thiel.2007.519">Thiel et al [2007]</a> and references therein). The decrease in rRNA cleavage caused by some pathogenic variants strongly correlates with the degree of bone dysplasia [<a class="bk_pop" href="#chh.REF.thiel.2007.519">Thiel et al 2007</a>], whereas the disruption of the rRNA cleavage function correlates with the degree to which additional features including hair hypoplasia, immunodeficiency, anemia, and susceptibility to cancer are present. However, the actual <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in persons with <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> <i>RMRP</i> transcript variants can be quite variable, depending on the functional impairment resulting from the specific combination of pathogenic variants.</p><div id="chh.T.rmrp_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>RMRP</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK84550/table/chh.T.rmrp_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chh.T.rmrp_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chh.T.rmrp_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_chh.T.rmrp_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_chh.T.rmrp_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequence</th></tr></thead><tbody><tr><td headers="hd_h_chh.T.rmrp_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">g.70A&#x0003e;G</td><td headers="hd_h_chh.T.rmrp_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not applicable</td><td headers="hd_h_chh.T.rmrp_pathogenic_variants_discussed_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NG_017041.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NG_017041<wbr style="display:inline-block"></wbr>​.1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>RMRP</i> encodes the untranslated RNA subunit of the ribonucleoprotein endoribonuclease complex RNase MRP [<a class="bk_pop" href="#chh.REF.ridanp__.2001.195">Ridanp&#x000e4;&#x000e4; et al 2001</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> transcript folds into a highly complex secondary structure and combines with at least ten proteins to form the mitochondrial RNA processing ribonuclease, RNase MRP, which is localized in the nucleolus and in mitochondria [<a class="bk_pop" href="#chh.REF.welting.2004.2138">Welting et al 2004</a>, <a class="bk_pop" href="#chh.REF.hermanns.2005.3723">Hermanns et al 2005</a>, <a class="bk_pop" href="#chh.REF.thiel.2005.795">Thiel et al 2005</a>, <a class="bk_pop" href="#chh.REF.thiel.2007.519">Thiel et al 2007</a>, <a class="bk_pop" href="#chh.REF.welting.2008.455">Welting et al 2008</a>]. This complex is involved in (1) 5.8S rRNA cleavage leading to mature 5.8S rRNA (a necessary step to complete ribosome assembly) and (2) cleavage of cyclin B1 mRNA (<i>CCNB1</i>) needed in cell-cycle regulation progression. RMRP also forms a complex with telomerase reverse transcriptase catalytic subunit (encoded by <i>TERT</i>), which may play a role in cellular senescence [<a class="bk_pop" href="#chh.REF.maida.2009.230">Maida et al 2009</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> None.</p></div><div id="chh.References"><h2 id="_chh_References_">References</h2><div id="chh.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="chh.REF.altenburg.2015.147">Altenburg J, Wortel K, van der Werf TS, Boersma WG. Non-cystic fibrosis bronchiectasis: clinical presentation, diagnosis and treatment, illustrated by data from a Dutch Teaching Hospital. <span><span class="ref-journal">Neth J Med. </span>2015;<span class="ref-vol">73</span>:147–54.</span> [<a href="/pubmed/25968285" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25968285</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.bacchetta.2009.2449">Bacchetta J, Ranchin B, Brunet AS, Bouvier R, Duquesne A, Edery P, Fabien N, Peretti N. Autoimmune hypoparathyroidism in a 12-year-old girl with McKusick cartilage hair hypoplasia. <span><span class="ref-journal">Pediatr Nephrol. </span>2009;<span class="ref-vol">24</span>:2449–53.</span> [<a href="/pubmed/19626344" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19626344</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.baillybotuha.2008.429">Bailly-Botuha C, Jaubert F, Taam RA, Galmiche L, Picard C, Bellon G, de Blic J. Diffuse lymphoplasmacytic bronchiolitis in cartilage-hair hypoplasia. <span><span class="ref-journal">J Pediatr. </span>2008;<span class="ref-vol">152</span>:429–33.</span> [<a href="/pubmed/18280854" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18280854</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.baradaranheravi.2008.2013">Baradaran-Heravi A, Thiel C, Rauch A, Zenker M, Boerkoel CF, Kaitila I. Clinical and genetic distinction of Schimke immuno-osseous dysplasia and cartilage-hair hypoplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:2013–7.</span> [<a href="/pmc/articles/PMC2576743/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2576743</span></a>] [<a href="/pubmed/18627050" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18627050</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.biggs.2017.508">Biggs CM, Kostjukovits S, Dobbs K, Laakso S, Klemetti P, Valta H, Taskinen M, M&#x000e4;kitie O, Notarangelo LD. Diverse autoantibody reactivity in cartilage-hair hypoplasia. <span><span class="ref-journal">J Clin Immunol. </span>2017;<span class="ref-vol">37</span>:508–10.</span> [<a href="/pmc/articles/PMC6104642/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6104642</span></a>] [<a href="/pubmed/28631025" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28631025</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.bonaf_.2005.e47">Bonaf&#x000e9; L, Dermitzakis ET, Unger S, Greenberg CR, Campos-Xavier BA, Zankl A, Ucla C, Antonarakis SE, Superti-Furga A, Reymond A. Evolutionary comparison provides evidence for pathogenicity of RMRP mutations. <span><span class="ref-journal">PLoS Genet. </span>2005;<span class="ref-vol">1</span>:e47.</span> [<a href="/pmc/articles/PMC1262189/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1262189</span></a>] [<a href="/pubmed/16244706" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16244706</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.bonaf_.2002.146">Bonaf&#x000e9; L, Schmitt K, Eich G, Giedion A, Superti-Furga A. RMRP gene sequence analysis confirms a cartilage-hair hypoplasia variant with only skeletal manifestations and reveals a high density of single-nucleotide polymorphisms. <span><span class="ref-journal">Clin Genet. </span>2002;<span class="ref-vol">61</span>:146–51.</span> [<a href="/pubmed/11940090" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11940090</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.bordon.2010.27">Bordon V, Gennery AR, Slatter MA, Vandecruys E, Laureys G, Veys P, Qasim W, Friedrich W, Wulfraat NM, Scherer F, Cant AJ, Fischer A, Cavazzana-Calvo M, Bredius RG, Notarangelo LD, Mazzolari E, Neven B, G&#x000fc;ng&#x000f6;r T., Inborn Error Working Party of the European Bone Marrow Transplantation (EBMT) Group.  Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation. <span><span class="ref-journal">Blood. </span>2010;<span class="ref-vol">116</span>:27–35.</span> [<a href="/pubmed/20375313" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20375313</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.cherkaoui_jaouad.2015.77">Cherkaoui Jaouad I, Laarabi FZ, Chafai Elalaoui S, Lyonnet S, Henrion-Caude A, Sefiani A. Novel mutation and structural RNA analysis of the noncoding RNase MRP gene in cartilage-hair hypoplasia. <span><span class="ref-journal">Mol Syndromol. </span>2015;<span class="ref-vol">6</span>:77–82.</span> [<a href="/pmc/articles/PMC4521058/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4521058</span></a>] [<a href="/pubmed/26279652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26279652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.guggenheim.2006.751">Guggenheim R, Somech R, Grunebaum E, Atkinson A, Roifman CM. Bone marrow transplantation for cartilage-hair-hypoplasia. <span><span class="ref-journal">Bone Marrow Transplant. </span>2006;<span class="ref-vol">38</span>:751–6.</span> [<a href="/pubmed/17041608" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17041608</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.hermanns.2005.3723">Hermanns P, Bertuch AA, Bertin TK, Dawson B, Schmitt ME, Shaw C, Zabel B, Lee B. Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia. <span><span class="ref-journal">Hum Mol Genet. </span>2005;<span class="ref-vol">14</span>:3723–40.</span> [<a href="/pubmed/16254002" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16254002</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.hermanns.2006.2121">Hermanns P, Tran A, Munivez E, Carter S, Zabel B, Lee B, Leroy JG. RMRP mutations in cartilage-hair hypoplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:2121–30.</span> [<a href="/pubmed/16838329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16838329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.holopainen.2018.422">Holopainen E, Vakkilainen S, M&#x000e4;kitie O. Diversity of pubertal development in cartilage-hair hypoplasia; two illustrative cases. <span><span class="ref-journal">J Pediatr Adolesc Gynecol. </span>2018;<span class="ref-vol">31</span>:422–5.</span> [<a href="/pubmed/29462708" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29462708</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.horn.2001.262">Horn D, Rupprecht E, Kunze J, Spranger J. Anauxetic dysplasia, a spondylometaepiphyseal dysplasia with extreme dwarfism. <span><span class="ref-journal">J Med Genet. </span>2001;<span class="ref-vol">38</span>:262–5.</span> [<a href="/pmc/articles/PMC1734840/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734840</span></a>] [<a href="/pubmed/11370632" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11370632</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.ip.2015.147">Ip W, Gaspar HB, Kleta R, Chanudet E, Bacchelli C, Pitts A, Nademi Z, Davies EG, Slatter MA, Amrolia P, Rao K, Veys P, Gennery AR, Qasim W. Variable phenotype of severe immunodeficiencies associated with RMRP gene mutations. <span><span class="ref-journal">J Clin Immunol. </span>2015;<span class="ref-vol">35</span>:147–57.</span> [<a href="/pubmed/25663137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25663137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.kainulainen.2014.256">Kainulainen L, Lassila O, Ruuskanen O. Cartilage-hair hypoplasia: follow-up of immunodeficiency in two patients. <span><span class="ref-journal">J Clin Immunol. </span>2014;<span class="ref-vol">34</span>:256–9.</span> [<a href="/pubmed/24402619" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24402619</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.kavadas.2008.1178">Kavadas FD, Giliani S, Gu Y, Mazzolari E, Bates A, Pegoiani E, Roifman CM, Notarangelo LD. Variability of clinical and laboratory features among patients with ribonuclease mitochondrial RNA processing endoribonuclease gene mutations. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2008;<span class="ref-vol">122</span>:1178–84.</span> [<a href="/pubmed/18804272" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18804272</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.klemetti.2017.204">Klemetti P, Valta H, Kostjukovits S, Taskinen M, Toiviainen-Salo S, M&#x000e4;kitie O. Cartilage-hair hypoplasia with normal height in childhood-4 patients with a unique genotype. <span><span class="ref-journal">Clin Genet. </span>2017;<span class="ref-vol">92</span>:204–7.</span> [<a href="/pubmed/28094436" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28094436</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.kostjukovits.2017a.375">Kostjukovits S, Klemetti P, F&#x000f6;hr A, Kajosaari M, Valta H, Taskinen M, Toiviainen-Salo S, M&#x000e4;kitie O. High prevalence of bronchiectasis in patients with cartilage-hair hypoplasia. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2017a;<span class="ref-vol">139</span>:375–8.</span> [<a href="/pubmed/27568079" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27568079</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.kostjukovits.2017b.612">Kostjukovits S, Klemetti P, Valta H, Martelius T, Notarangelo LD, Sepp&#x000e4;nen M, Taskinen M, M&#x000e4;kitie O. Analysis of clinical and immunologic phenotype in a large cohort of children and adults with cartilage-hair hypoplasia. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2017b;<span class="ref-vol">140</span>:612–4.e5.</span> [<a href="/pmc/articles/PMC5547008/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5547008</span></a>] [<a href="/pubmed/28284971" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28284971</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.kwan.2013.140">Kwan A, Church JA, Cowan MJ, Agarwal R, Kapoor N, Kohn DB, Lewis DB, McGhee SA, Moore TB, Stiehm ER, Porteus M, Aznar CP, Currier R, Lorey F, Puck JM. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2013;<span class="ref-vol">132</span>:140–50.</span> [<a href="/pmc/articles/PMC3759317/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3759317</span></a>] [<a href="/pubmed/23810098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23810098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.levin.2015.1066">Levin TL, M&#x000e4;kitie O, Berdon WE, Lachman RS. Shwachman-Bodian-Diamond syndrome: metaphyseal chondrodysplasia in children with pancreatic insufficiency and neutropenia. <span><span class="ref-journal">Pediatr Radiol. </span>2015;<span class="ref-vol">45</span>:1066–71.</span> [<a href="/pubmed/25416932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25416932</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.maida.2009.230">Maida Y, Yasukawa M, Furuuchi M, Lassmann T, Possemato R, Okamoto N, Kasim V, Hayashizaki Y, Hahn WC, Masutomi K. An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. <span><span class="ref-journal">Nature. </span>2009;<span class="ref-vol">461</span>:230–5.</span> [<a href="/pmc/articles/PMC2755635/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2755635</span></a>] [<a href="/pubmed/19701182" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19701182</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.m_kitie.1992.652">M&#x000e4;kitie O. Cartilage-hair hypoplasia in Finland: epidemiological and genetic aspects of 107 patients. <span><span class="ref-journal">J Med Genet. </span>1992;<span class="ref-vol">29</span>:652–5.</span> [<a href="/pmc/articles/PMC1016098/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1016098</span></a>] [<a href="/pubmed/1404295" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1404295</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.m_kitie.1993.211">M&#x000e4;kitie O, Kaitila I. Cartilage-hair hypoplasia--clinical manifestations in 108 Finnish patients. <span><span class="ref-journal">Eur J Pediatr. </span>1993;<span class="ref-vol">152</span>:211–7.</span> [<a href="/pubmed/8444246" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8444246</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.m_kitie.2001a.929">M&#x000e4;kitie O, Kaitila I, Rintala R. Hirschsprung disease associated with severe cartilage-hair hypoplasia. <span><span class="ref-journal">J Pediatr. </span>2001a;<span class="ref-vol">138</span>:929–31.</span> [<a href="/pubmed/11391344" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11391344</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.m_kitie.1998.816">M&#x000e4;kitie O, Kaitila I, Savilahti E. Susceptibility to infections and in vitro immune functions in cartilage-hair hypoplasia. <span><span class="ref-journal">Eur J Pediatr. </span>1998;<span class="ref-vol">157</span>:816–20.</span> [<a href="/pubmed/9809821" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9809821</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.m_kitie.1992a.176">M&#x000e4;kitie O, Perheentupa J, Kaitila I. Growth in cartilage-hair hypoplasia. <span><span class="ref-journal">Pediatr Res. </span>1992a;<span class="ref-vol">31</span>:176–80.</span> [<a href="/pubmed/1542548" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1542548</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.m_kitie.1999.315">M&#x000e4;kitie O, Pukkala E, Teppo L, Kaitila I. Increased incidence of cancer in patients with cartilage-hair hypoplasia. <span><span class="ref-journal">J Pediatr. </span>1999;<span class="ref-vol">134</span>:315–8.</span> [<a href="/pubmed/10064668" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10064668</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.m_kitie.1992b.1026">M&#x000e4;kitie O, Rajantie J, Kaitila I. Anaemia and macrocytosis--unrecognized features in cartilage-hair hypoplasia. <span><span class="ref-journal">Acta Paediatr. </span>1992b;<span class="ref-vol">81</span>:1026–9.</span> [<a href="/pubmed/1290847" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1290847</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.m_kitie.1995.39">M&#x000e4;kitie O, Sulisalo T, de la Chapelle A, Kaitila I. Cartilage-hair hypoplasia. <span><span class="ref-journal">J Med Genet. </span>1995;<span class="ref-vol">32</span>:39–43.</span> [<a href="/pmc/articles/PMC1050177/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1050177</span></a>] [<a href="/pubmed/7897625" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7897625</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.m_kitie.2001b.201">M&#x000e4;kitie OM, Tapanainen PJ, Dunkel L, Siimes MA. Impaired spermatogenesis: an unrecognized feature of cartilage-hair hypoplasia. <span><span class="ref-journal">Ann Med. </span>2001b;<span class="ref-vol">33</span>:201–5.</span> [<a href="/pubmed/11370774" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11370774</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.martin.2007.219">Martin AN, Li Y. RNase MRP RNA and human genetic diseases. <span><span class="ref-journal">Cell Res. </span>2007;<span class="ref-vol">17</span>:219–26.</span> [<a href="/pubmed/17189938" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17189938</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.mccann.2014.42">McCann LJ, McPartland J, Barge D, Strain L, Bourn D, Calonje E, Verbov J, Riordan A, Kokai G, Bacon CM, Wright M, Abinun M. Phenotypic variations of cartilage hair hypoplasia: granulomatous skin inflammation and severe T cell immunodeficiency as initial clinical presentation in otherwise well child with short stature. <span><span class="ref-journal">J Clin Immunol. </span>2014;<span class="ref-vol">34</span>:42–8.</span> [<a href="/pubmed/24217815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24217815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.mckusick.1965.285">McKusick VA, Eldridge R, Hostetler JA, Ruangwit U, Egeland JA. Dwarfism in the Amish. II. Cartilage-hair hypoplasia. <span><span class="ref-journal">Bull Johns Hopkins Hosp. </span>1965;<span class="ref-vol">116</span>:285–326.</span> [<a href="/pubmed/14284412" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14284412</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.moshous.2011.847">Moshous D, Meyts I, Fraitag S, Janssen CE, Debr&#x000e9; M, Suarez F, Toelen J, De Boeck K, Roskams T, Deschildre A, Picard C, Bodemer C, Wouters C, Fischer A. Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF-&#x003b1; mAbs. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2011;<span class="ref-vol">128</span>:847–53.</span> [<a href="/pubmed/21714993" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21714993</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.nakashima.2007.2675">Nakashima E, Tran JR, Welting TJ, Pruijn GJ, Hirose Y, Nishimura G, Ohashi H, Schurman SH, Cheng J, Candotti F, Nagaraja R, Ikegawa S, Schlessinger D. Cartilage hair hypoplasia mutations that lead to RMRP promoter inefficiency or RNA transcript instability. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:2675–81.</span> [<a href="/pubmed/17937437" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17937437</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.narra.2009.1418">Narra MB, Shearer WT. Cartilage-hair hypoplasia and severe allergy. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2009;<span class="ref-vol">123</span>:1418–9.</span> [<a href="/pubmed/19394685" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19394685</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.notarangelo.2008.534">Notarangelo LD, Roifman CM, Giliani S. Cartilage-hair hypoplasia: molecular basis and heterogeneity of the immunological phenotype. <span><span class="ref-journal">Curr Opin Allergy Clin Immunol. </span>2008;<span class="ref-vol">8</span>:534–9.</span> [<a href="/pubmed/18978468" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18978468</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.obaramoszynska.2013.e162">Obara-Moszynska M, Wielanowska W, Rojek A, Wolnik-Brzozowska D, Niedziela M. Treatment of cartilage-hair hypoplasia with recombinant human growth hormone. <span><span class="ref-journal">Pediatr Int. </span>2013;<span class="ref-vol">55</span>:e162–4.</span> [<a href="/pubmed/24330304" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24330304</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.ridanp__.2001.195">Ridanp&#x000e4;&#x000e4; M, van Eenennaam H, Pelin K, Chadwick R, Johnson C, Yuan B, vanVenrooij W, Pruijn G, Salmela R, Rockas S, M&#x000e4;kitie O, Kaitila I, de la Chapelle A. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. <span><span class="ref-journal">Cell. </span>2001;<span class="ref-vol">104</span>:195–203.</span> [<a href="/pubmed/11207361" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11207361</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.rider.2009.119">Rider NL, Morton DH, Puffenberger E, Hendrickson CL, Robinson DL, Strauss KA. Immunologic and clinical features of 25 Amish patients with RMRP 70 A--&#x0003e;G cartilage hair hypoplasia. <span><span class="ref-journal">Clin Immunol. </span>2009;<span class="ref-vol">131</span>:119–28.</span> [<a href="/pubmed/19150606" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19150606</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.riley.2015.145">Riley P Jr, Weiner DS, Leighley B, Jonah D, Morton DH, Strauss KA, Bober MB, Dicintio MS. Cartilage hair hypoplasia: characteristics and orthopaedic manifestations. <span><span class="ref-journal">J Child Orthop. </span>2015;<span class="ref-vol">9</span>:145–52.</span> [<a href="/pmc/articles/PMC4417732/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4417732</span></a>] [<a href="/pubmed/25764362" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25764362</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.roifman.2006.897">Roifman CM, Gu Y, Cohen A. Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2006;<span class="ref-vol">117</span>:897–903.</span> [<a href="/pubmed/16630949" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16630949</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.savoldi.2013.2614">Savoldi G, Izzi C, Signorelli M, Bondioni MP, Romani C, Lanzi G, Moratto D, Verdoni L, Pinotti M, Prefumo F, Superti-Furga A, Pilotta A. Prenatal presentation and postnatal evolution of a patient with Jansen metaphyseal dysplasia with a novel missense mutation in PTH1R. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:2614–9.</span> [<a href="/pubmed/23950054" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23950054</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.taskinen.2008.2370">Taskinen M, Ranki A, Pukkala E, Jeskanen L, Kaitila I, M&#x000e4;kitie O. Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:2370–5.</span> [<a href="/pubmed/18698627" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18698627</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.taskinen.2013.844">Taskinen M, Toiviainen-Salo S, Lohi J, Vuolukka P, Gr&#x000e4;sbeck M, M&#x000e4;kitie O. Hypoplastic anemia in cartilage-hair hypoplasia-balancing between iron overload and chelation. <span><span class="ref-journal">J Pediatr. </span>2013;<span class="ref-vol">162</span>:844–9.</span> [<a href="/pubmed/23140882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23140882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.thiel.2005.795">Thiel CT, Horn D, Zabel B, Ekici AB, Salinas K, Gebhart E, R&#x000fc;schendorf F, Sticht H, Spranger J, M&#x000fc;ller D, Zweier C, Schmitt ME, Reis A, Rauch A. Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">77</span>:795–806.</span> [<a href="/pmc/articles/PMC1271388/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1271388</span></a>] [<a href="/pubmed/16252239" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16252239</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.thiel.2007.519">Thiel CT, Mortier G, Kaitila I, Reis A, Rauch A. Type and level of RMRP functional impairment predicts phenotype in the cartilage hair hypoplasia-anauxetic dysplasia spectrum. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>:519–29.</span> [<a href="/pmc/articles/PMC1950841/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1950841</span></a>] [<a href="/pubmed/17701897" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17701897</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.thiel.2011.131">Thiel CT, Rauch A. The molecular basis of the cartilage-hair hypoplasia-anauxetic dysplasia spectrum. <span><span class="ref-journal">Best Pract Res Clin Endocrinol Metab. </span>2011;<span class="ref-vol">25</span>:131–42.</span> [<a href="/pubmed/21396580" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21396580</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.toiviainensalo.2008.422">Toiviainen-Salo S, Kajosaari M, Piilonen A, M&#x000e4;kitie O. Patients with cartilage-hair hypoplasia have an increased risk for bronchiectasis. <span><span class="ref-journal">J Pediatr. </span>2008;<span class="ref-vol">152</span>:422–8.</span> [<a href="/pubmed/18280853" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18280853</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.van_der_burgt.1991.371">van der Burgt I, Haraldsson A, Oosterwijk JC, van Essen AJ, Weemaes C, Hamel B. Cartilage hair hypoplasia, metaphyseal chondrodysplasia type McKusick: description of seven patients and review of the literature. <span><span class="ref-journal">Am J Med Genet. </span>1991;<span class="ref-vol">41</span>:371–80.</span> [<a href="/pubmed/1789294" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1789294</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.vatanavicharn.2010.523">Vatanavicharn N, Visitsunthorn N, Pho-iam T, Jirapongsananuruk O, Pacharn P, Chokephaibulkit K, Limwongse C, Wasant P. An infant with cartilage-hair hypoplasia due to a novel homozygous mutation in the promoter region of the RMRP gene associated with chondrodysplasia and severe immunodeficiency. <span><span class="ref-journal">J Appl Genet. </span>2010;<span class="ref-vol">51</span>:523–8.</span> [<a href="/pubmed/21063072" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21063072</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.welting.2008.455">Welting TJ, Mattijssen S, Peters FM, van Doorn NL, Dekkers L, van Venrooij WJ, Heus HA, Bonaf&#x000e9; L, Pruijn GJ. Cartilage-hair hypoplasia-associated mutations in the RNase MRP P3 domain affect RNA folding and ribonucleoprotein assembly. <span><span class="ref-journal">Biochim Biophys Acta. </span>2008;<span class="ref-vol">1783</span>:455–66.</span> [<a href="/pubmed/18164267" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18164267</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.welting.2004.2138">Welting TJ, van Venrooij WJ, Pruijn GJ. Mutual interactions between subunits of the human RNase MRP ribonucleoprotein complex. <span><span class="ref-journal">Nucleic Acids Res. </span>2004;<span class="ref-vol">32</span>:2138–46.</span> [<a href="/pmc/articles/PMC407822/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC407822</span></a>] [<a href="/pubmed/15096576" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15096576</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chh.REF.williams.2005.35">Williams MS, Ettinger RS, Hermanns P, Lee B, Carlsson G, Taskinen M, M&#x000e4;kitie O. The natural history of severe anemia in cartilage-hair hypoplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">138</span>:35–40.</span> [<a href="/pubmed/16097009" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16097009</span></a>]</div></li></ul></div></div><div id="chh.Chapter_Notes"><h2 id="_chh_Chapter_Notes_">Chapter Notes</h2><div id="chh.Author_History"><h3>Author History</h3><p>Svetlana (Kostjukovits) Vakkilainen, MD (2015-present)<br />Outi M&#x000e4;kitie, MD, PhD (2015-present)<br />Christian T Thiel, MD; Friedrich-Alexander Universit&#x000e4;t (2011-2015)</p></div><div id="chh.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>24 May 2018 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>13 August 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 March 2012 (me) Review posted live</div></li><li class="half_rhythm"><div>3 February 2011 (ct) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK84550</span><span class="label">PMID: <a href="/pubmed/22420014" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">22420014</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cpt2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cvt/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK84550&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK84550/?report=reader">PubReader</a></li><li><a href="/books/NBK84550/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK84550" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK84550" style="display:none" title="Cite this Page"><div class="bk_tt">Mäkitie O, Vakkilainen S. Cartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum Disorders. 2012 Mar 15 [Updated 2018 May 24]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK84550/pdf/Bookshelf_NBK84550.pdf">PDF version of this page</a> (495K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#chh.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#chh.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#chh.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#chh.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#chh.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#chh.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#chh.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#chh.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#chh.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#chh.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#chh.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#chh.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3908[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">LAMA2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6023[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RMRP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK84550+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2869830" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2869830" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2869830" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2869830" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17701897" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Type and level of RMRP functional impairment predicts phenotype in the cartilage hair hypoplasia-anauxetic dysplasia spectrum.</a><span class="source">[Am J Hum Genet. 2007]</span><div class="brieflinkpop offscreen_noflow">Type and level of RMRP functional impairment predicts phenotype in the cartilage hair hypoplasia-anauxetic dysplasia spectrum.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Thiel CT, Mortier G, Kaitila I, Reis A, Rauch A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2007 Sep; 81(3):519-29. Epub 2007 Aug 6.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24830047" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TRPV4</i>-Associated Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TRPV4</i>-Associated Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schindler A, Sumner C, Hoover-Fong JE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301567" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Robertson S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301584" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Severe Combined Immunodeficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Severe Combined Immunodeficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Allenspach E, Rawlings DJ, Scharenberg AM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301575" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mehta PA, Tolar J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=22420014" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=22420014" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc94d575f66d18aa0f05ee">Cartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum Disorders - GeneReviews...</a><div class="ralinkpop offscreen_noflow">Cartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:31:01-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AB367DFC84BA10000000007DC03E8&amp;ncbi_session=CE8AB367DFC94D51_2012SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK84550%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK84550&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK84550/&amp;ncbi_pagename=Cartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AB367DFC94D51_2012SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>